David Planchard, MD

Trials

Studies that name David Planchard, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:55 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07360743 · Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

  UNICANCER · recruiting · Non Small Cell Lung Cancer (Squamous or Non Squamous) · principal investigator
• Ph2
  NCT04940325 · Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

  Gustave Roussy, Cancer Campus, Grand Paris · active not recruiting · Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer, Unresectable Non-small Lung Cancer · study chair
• Ph3
  NCT04035486 · A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

  AstraZeneca · active not recruiting · Non-Small Cell Lung Cancer · principal investigator
• Ph1
  NCT02040064 · Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients

  Gustave Roussy, Cancer Campus, Grand Paris · completed · Non Small Cell Lung Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.